Sarcoidosis

Dail and Hammar's Pulmonary Pathology

Volumn 1, Issue , 2008, Pages 668-694

  Farver, Carol F ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 65849179672     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-0-387-68792-6_18     Document Type: Chapter

References (244)

1. Thomas PD, Hunninghake Gw. Current concepts of the pathogenesis of sarcoidosis. Am Rev Respir Dis 1987; 135(3):747-760.
2. Hutchinson 1. Case of livid papillary psoriasis. Illustrations of Clinical Surgery. London: J and A Churchill, 1877:42.
3. Boeck C. Multiple benign sarcoid of the skin. J Cutan Gen Urin Dis 1899;17:543-550.
4. Hunninghake GW, Costabel U, Ando M, et al. ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory SocietyIWorld Association of Sarcoidosis and other Granulomatous Disorders. Sarcoidosis Vasc Diffuse Lung Dis 1999;16(2):149-173.
5. Reich JM. Eight fundamental unsolved problems in sarcoidosis. Eur J Intern Med 2004;15(5):269-273.
6. Costabel U, Hunninghake Gw. ATS/ERS/WASOG statement on sarcoidosis. Sarcoidosis Statement Committee. American Thoracic Society. European Respiratory Society. World Association for Sarcoidosis and Other Granulomatous Disorders. Eur Respir J 1999;14(4):735-737.
7. Rybicki BA, Major M, Popovich J Jr, et al. Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am J Epidemiol 1997;145(3): 234-241.
8. Newman LS, Rose CS, Maier LA. Sarcoidosis. N Engl J Med 1997;336(17):1224-1234.
9. Milman N, Selroos 0. Pulmonary sarcoidosis in the Nordic countries 1950-1982. II. Course and prognosis. Sarcoidosis 1990;7(2):113-118.
10. Alsbirk PH. Epidemiologic studies on sarcoidosis in Denmark based on a nation-wide central register. A preliminary report. Acta Med Scand SuppI1964;425:106-109.
11. Byg KE, Milman N, Hansen S. Sarcoidosis in Denmark 1980-1994. A registry-based incidence study comprising c.F. Farver 5536 patients. Sarcoidosis Vasc Diffuse Lung Dis 2003; 20(1):46-52.
12. Hillerdal G, Nou E, Osterman K, et al. Sarcoidosis: epidemiology and prognosis. A 15-year European study. Am Rev Respir Dis 1984;130(1):29-32.
13. Henke CE, Henke G, Elveback LR, et al. The epidemiology of sarcoidosis in Rochester, Minnesota: a populationbased study of incidence and survival. Am J Epidemiol 1986;123(5):840-845.
14. Baculard A, Blanc N, Boule M, et al. Pulmonary sarcoidosis in children: a follow-up study. Eur Respir J 2001; 17(4):628-635.
15. Baughman RP, Lynch JP. Difficult treatment issues in sarcoidosis. J Intern Med 2003;253(1):41-45.
16. Moller DR, Chen ES. Genetic basis of remitting sarcoidosis: triumph of the trimolecular complex? Am J Respir Cell Mol Biol 2002;27(4):391-395.
17. Vourlekis JS, Sawyer RT, Newman LS. Sarcoidosis: developments in etiology, immunology, and therapeutics. Adv Intern Med 2000;45:209-257.
18. Ziegenhagen MW, Muller-Quernheim 1. The cytokine network in sarcoidosis and its clinical relevance. J Intern Med 2003;253(1):18-30.
19. Borchers AT, So C, Naguwa SM, et al. Clinical and immunologic components of sarcoidosis. Clin Rev Allergy Immuno 2003;25(3):289-303.
20. Baughman RP, Lower EE, du Bois RM. Sarcoidosis. Lancet 2003;361:1111-1118.
21. Martin WJ, Iannuzzi MC, Gail DB, et al. Future directions in sarcoidosis research: summary of an NHLBI working group. Am J Respir Crit Care Med 2004;170(5):567-571.
22. Muller-Quernheim 1. Sarcoidosis: immunopathogenetic concepts and their clinical application. Eur Respir J 1998; 12(3):716-738.
23. Moseley PL, Hemken C, Monick M, et al. Interferon and growth factor activity for human lung fibroblasts. Release from bronchoalveolar cells from patients with active sarcoidosis. Chest 1986;89(5):657-662.
24. Moller DR. Pulmonary fibrosis of sarcoidosis. New approaches, old ideas. Am J Respir Cell Mol BioI 2003; 29(3 suppl):S37-S41.
25. Moller DR. Treatment of sarcoidosis-from a basic science point of view. J Intern Med 2003;253(1):31-40.
26. Rosen Y, Vuletin JC, Pertschuk LP, et al. Sarcoidosis: from the pathologist's vantage point. Pathol Annu 1979;14(pt 1): 405-439.
27. Reich JM. What is sarcoidosis? Chest 2003;124(1): 367-371.
28. Iannuzzi MC, Maliarik M, Rybicki BA. Nomination of a candidate susceptibility gene in sarcoidosis: the complement receptor 1 gene. Am J Respir Cell Mol Biol 2002; 27(1):3-7.
29. Kon OM, du Bois RM. Mycobacteria and sarcoidosis. Thorax 1997;52(suppl 3):S47-S51.
30. Kent DC, Houk VN, Elliott RC, et al. The definitive evaluation of sarcoidosis. Am Rev Respir Dis 1970;101(5): 721-727.
31. Nethercott SE, Strawbridge WG. Identification of bacterial residues in sarcoid lesions. Lancet 1956;271(6953): 1132-1134.
32. Vanek J, Schwarz 1. Demonstration of acid-fast rods in sarcoidosis. Am Rev Respir Dis 11970;101(3):395-400.
33. Cantwell AR Jr. Histologic observations of variably acidfast pleomorphic bacteria in systemic sarcoidosis: a report of 3 cases. Growth 1982;46(2):113-125.
34. Bocart D, Lecossier D, De Lassence A, et al. A search for mycobacterial DNA in granulomatous tissues from patients with sarcoidosis using the polymerase chain reaction. Am Rev Respir Dis 1992;145(5):1142-1148.
35. Drake WP, Pei Z, Pride DT, et al. Molecular analysis of sarcoidosis tissues for mycobacterium species DNA. Emerg Infect Dis 2002;8(11):1334-1341.
36. Grosser M, Luther T, Muller J, et al. Detection of M. tuberculosis DNA in sarcoidosis: correlation with T-cell response. Lab Invest 1999;79(7):775-784.
37. Ikonomopoulos JA, Gorgoulis VG, Zacharatos PV, et al. Multiplex polymerase chain reaction for the detection of mycobacterial DNA in cases of tuberculosis and sarcoidosis. Mod Pathol 1999;12(9):854-862.
38. Saboor SA, Johnson NM, McFadden J. Detection of mycobacterial DNA in sarcoidosis and tuberculosis with polymerase chain reaction. Lancet 1992;339(8800): 1012-1015.
39. Li JY, Lo ST, Ng CS. Molecular detection of Mycobacterium tuberculosis in tissues showing granulomatous inflammation without demonstrable acid-fast bacilli. Diagn Mol Pathol2000;9(2):67-74.
40. Popper HH, Klemen H, Hoefler G, et al. Presence of mycobacterial DNA in sarcoidosis. Hum Pathol 1997;28(7): 796-800.
41. Klemen H, Husain AN, Cagle PT, et al. Mycobacterial DNA in recurrent sarcoidosis in the transplanted lunga PCR-based study on four cases. Virchows Arch 2000; 436(4):365-369.
42. Richter E, Greinert U, Kirsten D, et al. Assessment of mycobacterial DNA in cells and tissues of mycobacterial and sarcoid lesions. Am J Respir Crit Care Med 1996; 153(1):375-380.
43. du Bois RM, Goh N, McGrath D, et al. Is there a role for microorganisms in the pathogenesis of sarcoidosis? J Intern Med 2003;253(1):4-17.
44. Almenoff PL, Johnson A, Lesser M, et al. Growth of acid fast L forms from the blood of patients with sarcoidosis. Thorax 1996;51(5):530-533.
45. Gerdes J, Richter E, Rusch-Gerdes S, et al. Mycobacterial nucleic acids in sarcoid lesions. Lancet. 1992;339:1536-1537.
46. Ghossein RA, Ross DG, Salomon RN, et al. A search for mycobacterial DNA in sarcoidosis using the polymerase chain reaction. Am J Clin Pathol 11994; 101(6): 733-737.
47. Wilsher ML, Menzies RE, Croxson MC Mycobacterium tuberculosis DNA in tissues affected by sarcoidosis. Thorax 1998;53(10):871-874.
48. Milman N, Lisby G, Friis S, et al. Prolonged culture for mycobacteria in mediastinal lymph nodes from patients with pulmonary sarcoidosis. A negative study. Sarcoidosis Vasc Diffuse Lung Dis 2004;21(1):25-28.
49. Richter E, Kataria YP, Zissel G, et al. Analysis of the Kveim-Siltzbach test reagent for bacterial DNA. Am J Respir Crit Care Med 1999;159(6):1981-1984.
50. Vokurka M, Lecossier D, du Bois RM, et al. Absence of DNA from mycobacteria of the M. tuberculosis complex in sarcoidosis. Am J Respir Crit Care Med 1997;156: 1000-1003.
51. Brown ST, Brett I, Almenoff PL, et al. Recovery of cell wall-deficient organisms from blood does not distinguish between patients with sarcoidosis and control subjects. Chest 12003;123(2):413-417.
52. Minami J, Eishi Y, Ishige Y, et al. Pulmonary granulomas caused experimentally in mice by a recombinant triggerfactor protein of Propionibacterium acnes. J Med Dent Sci 2003;50(4):265-274.
53. Eishi Y, Suga M, Ishige I, et al. Quantitative analysis of mycobacterial and propionibacterial DNA in lymph nodes of Japanese and European patients with sarcoidosis. J Clin Microbiol 12002; 40(1): 198-204.
54. Ishige I, Usui Y, Takemura T, et al. Quantitative PCR of mycobacterial and propionibacterial DNA in lymph nodes of Japanese patients with sarcoidosis. Lancet 1999; 354(9173):120-123.
55. Nishiwaki T, Yoneyama H, Eishi Y, et al. Indigenous pulmonary Propionibacterium acnes primes the host in the development of sarcoid-like pulmonary granulomatosis in mice. Am J Pathol 2004;165(2):631-639.
56. Nilsson K, Pahlson C, Lukinius A, et al. Presence of Rickettsia helvetica in granulomatous tissue from patients with sarcoidosis. J Infect Dis 2002;185(8):1128-1138.
57. Puolakkainen M, Campbell LA, Kuo CC, et al. Serological response to Chlamydia pneumoniae in patients with sarcoidosis. J Infect 1996;33(3):199-205.
58. Jacob F. Could Borrelia burgdorferi be a causal agent of sarcoidosis? Med Hypotheses 1989;30(4):241-243.
59. Ishihara M, Ohno S, Ono H, et al. Seroprevalence of anti-Borrelia antibodies among patients with confirmed sarcoidosis in a region of Japan where Lyme borreliosis is endemic. Graefes Arch Clin Exp Ophthalmol 1998; 236(4):280-284.
60. Mitchell DN, McSwiggan DA, Mikhail JR, et al. Antibody to herpes-like virus in sarcoidosis. Am Rev Respir Dis 1975;111(6):880-882.
61. Gazouli M, Ikonomopoulos J, Trigidou R, et al. Assessment of mycobacterial, propionibacterial, and human herpesvirus 8 DNA in tissues of Greek patients with sarcoidosis. J Clin Microbiol 2002;40(8):3060-3063.
62. Di Alberti L, Piattelli A, Artese L, et al. Human herpesvirus 8 variants in sarcoid tissues. Lancet 1997;350:1655-1661.
63. Kreider ME, Christie JD, Thompson B, et al. Relationship of environmental exposures to the clinical phenotype of sarcoidosis. Chest 2005;128(1):207-215.
64. Newman LS, Rose CS, Bresnitz EA, et al. A case control etiologic study of sarcoidosis: environmental and occupational risk factors. Am J Respir Crit Care Med 2004; 170(12):1324-1330.
65. Sharma OP, Neville E, Walker AN, et al. Familial sarcoidosis: a possible genetic influence. Ann NY Acad Sci 1976; 278:386-400.
66. Rybicki BA, Maliarik MJ, Major M, et al. Epidemiology, demographics, and genetics of sarcoidosis. Semin Respir Infect 1998;13(3):166-173.
67. McGrath DS, Daniil Z, Foley P, et al. Epidemiology of familial sarcoidosis in the UK. Thorax 2000;55(9): 751-754.
68. Rybicki BA, Iannuzzi MC, Frederick MM, et al. Familial aggregation of sarcoidosis. A case-control etiologic study of sarcoidosis (ACCESS). Am J Respir Crit Care Med 2001;164(11):2085-2091.
69. McIntyre JA, McKee KT, Loadholt CB, et al. Increased HLA-B7 antigen frequency in South Carolina blacks in association with sarcoidosis. Transplant Proc 1977;9(1 suppll):173-176.
70. Grunewald J, Eklund A, Olerup 0. Human leukocyte antigen class I alleles and the disease course in sarcoidosis patients. Am J Respir Crit Care Med 2004;169(6): 696-702.
71. Rossman MD, Thompson B, Frederick M, et al. HLADRB1 1101: a significant risk factor for sarcoidosis in blacks and whites. Am J Hum Genet 2003;73(4):720-735.
72. Rossman M, Thompson B, Frederick M, et al. Sarcoidosis: association with human leukocyte antigen class II amino acid epitopes and interaction with environmental exposures. Chest 2002;121 (3 suppl):14S.
73. du Bois RM. The genetic predisposition to interstitial lung disease: functional relevance. Chest 2002;121(3 supp!): 14S-20S.
74. Odum N, Milman N, Jakobsen BK, et al. HLA class II (D R, DQ, DP) in patients with sarcoidosis: evidence of an increased frequency of DRw6. Exp Clin Immunogenet 1991;8(4):227-232.
75. Maliarik MJ, Chen KM, Major ML, et al. Analysis of HLADPB1 polymorphisms in African-Americans with sarcoidosis. Am J Respir Crit Care Med 1998;158(1):111-114.
76. Sato H, Grutters JC, Pant eli dis P, et al. HLA-DQBl 0201: a marker for good prognosis in British and Dutch patients with sarcoidosis. Am J Respir Cell Mol Bioi 2002;27(4): 406-412.
77. Schurmann M, Lympany PA, Reichel P, et al. Familial sarcoidosis is linked to the major histocompatibility complex region. Am J Respir Crit Care Med 2000;162:861-864.
78. Schurmann M, Reichel P, Muller-Myhsok B, et al. Results from a genome-wide search for predisposing genes in sarcoidosis. Am J Respir Crit Care Med 2001;164(5): 840-846.
79. Foley PJ, McGrath DS, Puscinska E, et al. Human leukocyte antigen-DRB1 position 11 residues are a common protective marker for sarcoidosis. Am J Respir Cell Mol Bioi 2001;25(3):272-277.
80. Schurmann M, Bein G, Kirsten D, et al. HLA-DQBl and HLA-DPBl genotypes in familial sarcoidosis. Respir Med 1998;92(4):649-652.
81. Ina Y, Takada K, Yamamoto M, et al. HLA and sarcoidosis in the Japanese. Chest 1989;95(6):1257-1261.
82. Kunikane H, Abe S, Yamaguchi E, et al. Analysis of restriction fragment length polymorphism for the HLA-DR gene in Japanese patients with sarcoidosis. Thorax 1994;49(6): 573-576.
83. Swider C, Schnittger L, Bogunia-Kubik K, et al. TNF-alpha and HLA-DR genotyping as potential prognostic markers in pulmonary sarcoidosis. Eur Cytokine Netw 1999;10(2): 143-146. c.F. Farver
84. Berlin M, Fogdell-Hahn A, Olerup 0, et al. HLA-DR predicts the prognosis in Scandinavian patients with pulmonary sarcoidosis. Am J Respir Crit Care Med 1997;156(5): 1601-1605.
85. Grunewald J, Berlin M, Olerup 0, et al. Lung T-helper cells expressing T-cell receptor AV2S3 associate with clinical features of pulmonary sarcoidosis. Am J Respir Crit Care Med 2000;161:814-818.
86. Petrek M, Drabek J, Kolek V, et al. CC chemokine receptor gene polymorphisms in Czech patients with pulmonary sarcoidosis. Am J Respir Crit Care Med 2000;162:1000-1003.
87. McGrath DS, Foley PJ, Petrek M, et al. Ace gene IID polymorphism and sarcoidosis pulmonary disease severity. Am J Respir Crit Care Med 2001;164(2):197-201.
88. Morohashi K, Takada T, Omori K, et al. Vascular endothelial growth factor gene polymorphisms in Japanese patients with sarcoidosis. Chest 2003;123(5):1520-1526.
89. Spagnolo P, Renzoni EA, Wells AU, et al. C-C chemokine receptor 2 and sarcoidosis: association with Lofgren's syndrome. Am J Respir Crit Care Med 2003;168(10): 1162-1166.
90. Tobin MJ. Tuberculosis, lung infections, and interstitial lung disease in AJRCCM 2000. Am J Respir Crit Care Med 2001;164:1774-1788.
91. Baughman RP, Teirstein AS, Judson MA, et al. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med 2001;164: 1885-1889.
92. Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 1999;160(2): 736-755.
93. Lynch Jp, III, Kazerooni EA, Gay SE. Pulmonary sarcoidosis. Clin Chest Med 1997;18(4):755-785.
94. McLoud TC, Epler G R, Gaensler EA, et al. A radiographic classification for sarcoidosis: physiologic correlation. Invest Radiol 1982;17(2):129-138.
95. Scadding JO. Prognosis of intrathoracic sarcoidosis in England. A review of 136 cases after five years' observation. Br Med J 1961;5261:1165-1172.
96. Schabel SI, Foote GA, McKee KA. Posterior lymphadenopathy in sarcoidosis. Radiology 1978;129(3):591-593.
97. Siltzbach LE. Sarcoidosis: clinical features and management. Med Clin North Am 1967;51(2):483-502.
98. Neville E, Walker AN, James DO. Prognostic factors predicting the outcome of sarcoidosis: an analysis of 818 patients. Q J Med 1983;52(208):525-533.
99. Clarke D, Mitchell AW, Dick R, et al. The radiology of sarcoidosis. Sarcoidosis 1994;11(2):90-99.
100. Pipavath S, Godwin JD. Imaging of interstitial lung disease. Clin Chest Med 2004;25(3):455-456.
101. Wells A. High resolution computed tomography in sarcoidosis: a clinical perspective. Sarcoidosis Vase Diffuse Lung Dis 1998;15(2):140-146.
102. van der Schoot JB, Groen AS, de Jong 1. Gallium-67 scintigraphy in lung diseases. Thorax 1972;27(5):543-546.
103. Rizzato G, Blasi A. A European survey on the usefulness of 67Ga lung scans in assessing sarcoidosis. Experience in 14 research centers in seven different countries. Ann NY Acad Sci 1986;465:463-478.
104. Brantley SD, Orzel JA, Weiland FL, et al. Parotid gland biopsy and 67Ga imaging correlation in systemic sarcoidosis. Chest 1987;91(3):403-407.
105. Karma A, Poukkula AA, Ruokonen AO. Assessment of activity of ocular sarcoidosis by gallium scanning. Br J Ophthalmo 11987;71(5):361-367.
106. Mishkin FS, Tanaka TT, Niden AH. Abnormal gallium scan patterns of the salivary gland in pulmonary sarcoidosis. Ann Intern Med 1978;89(6):933-934.
107. Mana 1. Nuclear imaging. 67Gallium, 201 thallium, 18F-Iabeled fluoro-2-deoxy-D-glucose positron emission tomography. Clin Chest Med 1997;18(4):799-711.
108. Israel HL, Albertine KH, Park CH, et al. Whole-body gallium 67 scans. Role in diagnosis of sarcoidosis. Am Rev Respir Dis 1991;144(5):1182-1186.
109. Sheffield EA. Pathology of sarcoidosis. Clin Chest Med 1997;18(4):741-754.
110. Dunn TL, Watters LC, Hendrix C, et al. Gas exchange at a given degree of volume restriction is different in sarcoidosis and idiopathic pulmonary fibrosis. Am J Med 1988; 85(2):221-224.
111. Harrison BD, Shaylor JM, Stokes TC, et al. Airflow limitation in sarcoidosis-a study of pulmonary function in 107 patients with newly diagnosed disease. Respir Med 1991; 85(1):59-64.
112. Shorr AF, Torrington KG, Hnatiuk Ow. Endobronchial involvement and airway hyperreactivity in patients with sarcoidosis. Chest 2001;120(3):881-886.
113. Bechtel JJ, Starr T III, Dantzker DR, et al. Airway hyperreactivity in patients with sarcoidosis. Am Rev Respir Dis 1981;124(6):759-761.
114. Huang CT, Heurich AE, Rosen Y, et al. Pulmonary sarcoidosis: roentgenographic, functional, and pathologic correlations. Respiration 1979;37(6):337-345.
115. Young RC Jr, Carr C, Shelton TG, et al. Sarcoidosis: relationship between changes in lung structure and function. Am Rev Respir Dis 1967;95(2):224-238.
116. Carrington CB. Structure and function in sarcoidosis. Ann NY Acad Sci 1976;278:265-283.
117. Young RL, Lordon RE, Krumholz RA, et al. Pulmonary sarcoidosis. 1. Pathophysiologic correlations. Am Rev Respir Dis 1968;97(6):997-1008.
118. Lama VN, Martinez F1. Resting and exercise physiology in interstitial lung diseases. Clin Chest Med 2004;25(3): 435-453.
119. James DG, Turiaf J, Hosoda Y, et al. Description of sarcoidosis: Report of the Subcommittee on Classification and Definition. Ann N Y Acad Sci 1976;278:742.
120. Mason RS, Frankel T, Chan YL, et al. Vitamin D conversion by sarcoid lymph node homogenate. Ann Intern Med 1984;100(1):59-61.
121. Costabel U, Teschler H. Biochemical changes in sarcoidosis. Clin Chest Med 1997;18(4):827-842.
122. Eklund A, Blaschke E, Danielsson B. Subcellular localization of angiotensin-converting enzyme in the human alveolar macrophage. Scand J C1in Lab Invest 1987;47(1):47-54.
123. Lieberman 1. Elevation of serum angiotensin-convertingenzyme (ACE) level in sarcoidosis. Am J Med 1975;59(3): 365-372.
124. Lieberman 1. The specificity and nature of serumangiotensin-converting enzyme (serum ACE) elevations in sarcoidosis. Ann N Y Acad Sci 1976;278:488-497.
125. Munro CS, Mitchell DN, Poulter LW, et al. Early cellular responses to intradermal injection of Kveim suspension in normal subjects and those with sarcoidosis. J Clin Pathol 1986;39(2):176-182.
126. Costa bel U, King TE. International consensus statement on idiopathic pulmonary fibrosis. Eur Respir J 2001;17(2): 163-167.
127. Teirstein AS, Judson MA, Baughman RP, et al. The spectrum of biopsy sites for the diagnosis of sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2005;22(2):139-146.
128. Descombes E, Gardiol D, Leuenberger P. Transbronchial lung biopsy: an analysis of 530 cases with reference to the number of samples. Monaldi Arch Chest Dis 1997;52(4): 324-329.
129. Koontz CH, Joyner LR, Nelson RA. Transbronchiallung biopsy via the fiberoptic bronchoscope in sarcoidosis. Ann Intern Med 1976;85(1):64-66.
130. Whitcomb ME, Hawley PC, Domby WR, et al. The role of fiberoptic bronchoscopy in the diagnosis of sarcoidosis. Clinical conference in pulmonary disease from Ohio State University, Columbus. Chest 1978;74(2):205-208.
131. Friedman OH, Blaugrund SM, Siltzbach LE. Biopsy of the bronchial wall as an aid in diagnosis of sarcoidosis. JAMA 1963;183:646-650.
132. Halme M, Piilonen A, Taskinen E. Comparison of endobronchial and transbronchial biopsies with high-resolution CT (HRCT) in the diagnosis of sarcoidosis. APMIS 2001;109(4):289-294.
133. Gilman MJ, Wang KP. Transbronchial lung biopsy in sarcoidosis. An approach to determine the optimal number of biopsies. Am Rev Respir Dis 1980;122(5):721-724.
134. Koerner SK, Sakowitz AJ, Appelman RI, et al. Transbronchiallung biopsy for the diagnosis of sarcoidosis. N Engl J Med 1975;293(6):268-270.
135. Roethe RA, Fuller PB, Byrd RB, et al. Transbronchoscopic lung biopsy in sarcoidosis. Optimal number and sites for diagnosis. Chest 1980;77(3):400-402.
136. Chapman JT, Mehta AC. Bronchoscopy in sarcoidosis: diagnostic and therapeutic interventions. Curr Opin Pulm Med 2003;9(5):402-407.
137. Gupta D, Mahendran C, Aggarwal AN, et al. Endobronchial vis a vis trans bronchial involvement on fiberoptic bronchoscopy in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2001;18(1):91-92.
138. Armstrong JR, Radke JR, Kvale PA, et al. Endoscopic findings in sarcoidosis. Characteristics and correlations with radiographic staging and bronchial mucosal biopsy yield. Ann Otol Rhinol Laryngol 1981;90:339-343.
139. Wang KP, Fuenning C, Johns CJ, et al. Flexible transbronchial needle aspiration for the diagnosis of sarcoidosis. Ann Otol Rhinol Laryngol 1989;98:298-300.
140. Mehta AC, Kavuru MS, Meeker DP, et al. Transbronchial needle aspiration for histology specimens. Chest 1989;96(6): 1228-1232.
141. Cetinkaya E, Yildiz P, Altin S, et al. Diagnostic value of trans bronchial needle aspiration by Wang 22-gauge cytology needle in intrathoracic lymphadenopathy. Chest 2004; 125(2):527-531.
142. Morales CF, Patefield AJ, Strollo P J Jr, et al. Flexible transbronchial needle aspiration in the diagnosis of sarcoidosis. Chest 1994;106(3):709-711.
143. Leonard C, Tormey VJ, O'Keane C, et al. Bronchoscopic diagnosis of sarcoidosis. Eur Respir J 1997;10(12): 2722-2724.
144. Bilaceroglu S, Perim K, Gunel 0, et al. Combining transbronchial aspiration with endobronchial and transbronchial biopsy in sarcoidosis. Monaldi Arch Chest Dis 1999; 54(3):217-223.
145. Trisolini R, Agli LL. The value of flexible transbronchial needle aspiration in the diagnosis of stage I sarcoidosis. Chest 2003;124;6:2126-2130.
146. Takayama K, Nagata N, Miyagawa Y, et al. The usefulness of step sectioning of trans bronchial lung biopsy specimen in diagnosing sarcoidosis. Chest 1992;102(5): 1441-1443.
147. Hsu RM, Connors AF Jr, Tomashefski JF Jr. Histologic, microbiologic, and clinical correlates of the diagnosis of sarcoidosis by transbronchial biopsy. Arch Pathol Lab Med 1996;120(4):364-368.
148. James DG, Rizzato G, Sharma OP. Bronchopulmonary lavage (BAL).A window of the lungs. Sarcoidosis 1992;9(1): 3-14.
149. Winterbauer RH, Lammert J, Selland M, et al. Bronchoalveolar lavage cell populations in the diagnosis of sarcoidosis. Chest 1993;104(2):352-361.
150. Wahlstrom J, Berlin M, Skold CM, et al. Phenotypic analysis of lymphocytes and monocytes/macrophages in peripheral blood and bronchoalveolar lavage fluid from patients with pulmonary sarcoidosis. Thorax 1999;54(4): 339-346.
151. Kantrow SP, Meyer KC, Kidd P, et al. The CD4/CD8 ratio in BAL fluid is highly variable in sarcoidosis. Eur Respir J 1997;10(12):2716-2721.
152. Milman N, Graudal N, Jacobsen GK. Bronchoalveolar lavage in radiologically detected diffuse lung disease. Diagnostic value of total and differential cell count in a series of 130 patients. APMIS 1995;103(10):764-768.
153. Poulter LW, Rossi GA, Bjermer L, et al. The value of bronchoalveolar lavage in the diagnosis and prognosis of sarcoidosis. Eur Respir J 1990;3(8):943-944.
154. Ward K, O'Connor C, OdIum C, et al. Prognostic value of bronchoalveolar lavage in sarcoidosis: the critical influence of disease presentation. Thorax 1989;44(1):6-12.
155. Drent M, Jacobs JA, de Vries J, et al. Does the cellular bronchoalveolar lavage fluid profile reflect the severity of sarcoidosis? Eur Respir J 1999;13(6):1338-1344.
156. Baughman RP. Pulmonary sarcoidosis. Clin Chest Med 2004;25(3):521-530, vi.
157. Judson MA, Baughman RP, Thompson BW, et al. Two year prognosis of sarcoidosis: the ACCESS experience. Sarcoidosis Vasc Diffuse Lung Dis 2003;20(3):204-211.
158. Reich JM. Mortality of intrathoracic sarcoidosis in referral vs population-based settings: influence of stage, ethnicity, and corticosteroid therapy. Chest 2002;121(1):32-39. c.F. Farver
159. Reich JM, Johnson RE. Course and prognosis of sarcoidosis in a nonreferral setting. Analysis of 86 patients observed for 10 years. Am J Med 1985;78(1):61-67.
160. Seitzer U, Gerdes J, Muller-Quernheim 1. Genotyping in the MHC locus: potential for defining predictive markers in sarcoidosis. Respir Res 2002;3(1): 6.
161. Culver DA, Thomassen MJ, Kavuru MS. Pulmonary sarcoidosis: new genetic clues and ongoing treatment controversies. Cleve Clin J Med 2004;71 (2):88, 90, 92.
162. Baughman RP, Lower EE. A clinical approach to the use of methotrexate for sarcoidosis. Thorax 1999;54(8): 742-746.
163. Hunninghake GW. Goal of the treatment for sarcoidosis. Minimize harm for the patient. Am J Respir Crit Care Med 1997;156(5):1369-1370.
164. Shorr AF, Helman DL, Davies DB, et al. Sarcoidosis, race, and short-term outcomes following lung transplantation. Chest 12004;125(3):990-996.
165. Nunley DR, Hattler B, Keenan RJ, et al. Lung transplantation for end-stage pulmonary sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 1999;16(1):93-100.
166. Adams DO. The biology of the granuloma. In: Ioachim HL, ed. Pathology of granulomas. New York: Raven Press, 1983: 1-20.
167. Uehlinger EA. The morbid anatomy of sarcoidosis. Am Rev Respir Dis 1961;84(5, pt 2):6-13.
168. Roman J, Galis ZS. Sarcoidosis: a mysterious tale of inflammation, tissue remodeling, and matrix metalloproteinases. Hum Patho 12002;33(12):1155-1157.
169. Ricker W. Sarcoidosis: a clinicopathologic review of three hundred cases, including twenty-two autopsies. Am J Clin PathoI1949;19:725-749.
170. Teilum G. Morphogenesis and development of sarcoid lesions. Similarities to the group of collagenoses. Acta Med Scand Suppl 1964;425:14-18.
171. Ziegenhagen MW, Rothe ME, Zissel G, et al. Exaggerated TNFalpha release of alveolar macrophages in corticosteroid resistant sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2002;19(3):185-190.
172. Black MM, Epstein WL. Formation of multinucleate giant cells in organized epithelioid cell granulomas. Am J Pathol 1974;74(2):263-274.
173. Bybee JD, Bahar D, Greenberg SD, et al. Bronchoscopy and bronchial mucosal biopsy in the diagnosis of sarcoidosis. Am Rev Respir Dis 1968;97(2):232-239.
174. Cohen M, Sahn SA. Bronchiectasis in systemic diseases. Chest 1999;116(4):1063-1074.
175. Goldenberg GJ, Greenspan RH. Middle-lobe atelectasis due to endobronchial sarcoidosis, with hypercalcemia and renal impairment. N Engl J Med 1960;262:1112-1116.
176. Westcott JL, Noehren TH. Bronchial stenosis in chronic sarcoidosis. Chest 1973;63(6):893-897.
177. Hadfield JW, Page RL, Flower CD, et al. Localised airway narrowing in sarcoidosis. Thorax 1982;37(6):443-447.
178. Sharma OP, Hewlett R, Gordonson 1. Nodular sarcoidosis: an unusual radiographic appearance. Chest 1973;64(2): 189-192.
179. Kurogouchi F, Fujimori Y, Oharazawa A, et al. Sarcoidosis associated with multiple large pulmonary nodules. Respirology 1998;3(4):273-276.
180. Rosen Y. Sarcoidosis. In Dail DH, Hammar SP, eds. Pulmonary pathology. 2nd ed. New York: Springer-Verlag, 1995:615645.
181. Aiello M, Chetta A, Marangio E, et al. Pleural involvement in systemic disorders. Curr Drug Targets lnflamm Allergy 2004;3(4):441-447.
182. Wilen SB, Rabinowitz lG, Ulreich S, et al. Pleural involvement in sarcoidosis. Am 1 Med 1974;57(2):200-209.
183. Chusid EL, Siltzbach LE. Sarcoidosis of the pleura. Ann Intern Med 1974;81(2):190-194.
184. Blackmon GM, Raghu G. Pulmonary sarcoidosis: a mimic of respiratory infection. Semin Respir Infect 1995;10(3): 176-186.
185. Brauner MW, Grenier P, Mompoint D, et al. Pulmonary sarcoidosis: evaluation with high-resolution CT. Radiology 1989;172(2):467-471.
186. Ohmichi M, Hiraga Y, Hirasawa M. Pulmonary involvements of sarcoidosis. Nihon Kyobu Shikkan Gakkai Zasshi 1990;28(1):48-55.
187. Soskel NT, Sharma OP. Pleural involvement in sarcoidosis. Curr Opin Pulmon Med 2000;6(5):455-468.
188. Takemura T, Matsui Y, Oritsu M, et al. Pulmonary vascular involvement in sarcoidosis: granulomatous angiitis and micro angiopathy in trans bronchial lung biopsies. Virchows Arch A Pathol Anat Histopatho 1991;418(4):361-368.
189. Yamaguchi T, Yokoyama T, Koike M. A histologic and histometric study of trans bronchial lung biopsy in pulmonary sarcoidosis. Nihon Kyobu Shikkan Gakkai Zasshi 1986; 24(3):264-271.
190. Rosen Y, Moon S, Huang CT, et al. Granulomatous pulmonary angiitis in sarcoidosis. Arch Pathol Lab Med 1977; 101(4):170-174.
191. Takemura T, Matsui Y, Saiki S, et al. Pulmonary vascular involvement in sarcoidosis: a report of 40 autopsy cases. Hum Patho 1992;23(11):1216-1223.
192. Battesti JP, Georges R, Basset F, et al. Chronic cor pulmonale in pulmonary sarcoidosis. Thorax 1978;33(1):76-84.
193. Smith LJ, Lawrence JB, Katzenstein AA. Vascular sarcoidosis: a rare cause of pulmonary hypertension. Am 1 Med Sci 1983;285(1):38-44.
194. Levine BW, Saldana M, Hutter AM. Pulmonary hypertension in sarcoidosis. A case report of a rare but potentially treatable cause. Am Rev Respir Dis 1971;103(3):413-417.
195. Hoffstein V, Ranganathan N, Mullen lB. Sarcoidosis simulating pulmonary veno-occlusive disease. Am Rev Respir Dis 1986;134(4):809-811.
196. Iwai K, Takemura T, Kitaichi M, et al. Pathological studies on sarcoidosis autopsy. II. Early change, mode of progression and death pattern. Acta Pathol Jpn 1993;43(7-8): 377-385.
197. Hennebicque AS, Nunes H, Brillet PY, et al. CT findings in severe thoracic sarcoidosis. Eur Radiol 2005;15(1): 23-30.
198. Schaum ann J. Schaumann bodies. Acta Med Scand 1941;106:239.
199. Topal AN, Canda MS, Gunel O. Schaumann bodies in bronchial and bronchioalveolar lavage fluid in a case of sarcoidosis. Acta Cytol 2003;47(2):320-321.
200. Aisner SC, Gupta PK, Frost JK. Sputum cytology in pulmonary sarcoidosis. Acta Cytol 1977;21(3):394-398.
201. Williams WL, Wallach ER. Laser microprobe mass spectrometry (LAMMS) analysis of beryllium, sarcoidosis and other granulomatous diseases. Sarcoidosis 1989;6(2):111-117.
202. Kirkpatrick Cl, Curry A, Bisset DL. Light and electron microscopic studies on multinucleated giant cells in sarcoid granuloma: new aspects of asteroid and Schaumann bodies. Ultrastruct Pathol 1988;12(6):581-597.
203. Reid LD, Andersen ME. Calcium oxalate in sarcoid granulomas. With particular reference to the small ovoid body and a note on the finding of dolomite. Am I Clin Pathol 1988;90(5):545-558.
204. Jones WW. The nature and origin of Schaumann bodies. J Pathol BacterioI1960;79:193-101.
205. Cain H, Kraus B. Immunofluorescence microscopic demonstration of vimentin filaments in asteroid bodies of sarcoidosis. A comparison with electron microscopic findings. Virchows Arch B Cell Pathol Incl Mol Pathol 1983;42(2): 213-226.
206. Cain H, Kraus B. Asteroid bodies: derivatives of the cytosphere. An electron microscopic contribution to the pathology of the cytocentre. Virchows Arch B Cell Pathol 1977; 26(2):119-132.
207. Gadde PS, Moscovic EA. Asteroid bodies: products of unusual microtubule dynamics in monocyte-derived giant cells. An immunohistochemical study. Histol Histopathol 1994;9(4):633-642.
208. Brenner DS, Drachenberg CB, Papadimitriou LC. Structural similarities between hematoidin crystals and asteroid bodies: evidence of lipid composition. Exp Mol Pathol 2001;70(1):37-42.
209. Papadimitriou LC, Drachenberg CB. Ultrastructural analysis of asteroid bodies: evidence for membrane lipid bilayer nature of components. Ultrastruct Pathol 1992; 16(4):413-21.
210. Wargotz ES, Jannotta F. Asteroid bodies. Acta Cyto 111986; 30(5): 556-558.
211. Doyle WF, Brahman HD, Burgess LH. The nature of yellow-brown bodies in peritoneal lymph nodes. Arch Pathol 1973;96(5):320-326.
212. Gal AA, Koss MN. The pathology of sarcoidosis. Curr Opin Pulmon Med 2002;8(5):445-451.
213. Crystal RG, Gadek JE, Ferrans VL, et al. Interstitial lung disease: current concepts of pathogenesis, staging and therapy. Am I Med 1981;70(3):542-568.
214. Rosen Y, Athanassiades TJ, Moon S, et al. Nongranulomatous interstitial pneumonitis in sarcoidosis. Relationship to development of epithelioid granulomas. Chest 1978;74(2): 122-125.
215. Perez RL, Rivera-Marrero CA, Roman 1. Pulmonary granulomatous inflammation: from sarcoidosis to tuberculosis. Semin Respir Infect 2003;18(1):23-32.
216. Agostini C, Facco M, Chilosi M, et al. Alveolar macrophage-T cell interactions during Thl-type sarcoid inflammation. Microsc Res Tech 2001;53(4):278-287.
217. Colby TB. Infiltrative lung disease. In Thurlbeck WM, Churg AM, eds. Pathology of the lung. 2nd ed. New York: Thieme Medical; 1995:589-738.
218. Karakantza M, Matutes E, MacLennan K, et al. Association between sarcoidosis and lymphoma revisited. J Clin Pathol 1996;49(3):208-212.
219. Askling J, Grunewald J, Eklund A, et al. Increased risk for cancer following sarcoidosis. Am J Respir Crit Care Med 1999;160(5 Pt 1):1668-1672.
220. Brincker H. Sarcoid reactions in malignant tumours. Cancer Treat Rev 1986;13(3):147-156.
221. Brincker H, Wilbek E. The incidence of malignant tumours in patients with respiratory sarcoidosis. Br J Cancer 1974; 29(3):247-251.
222. Sato Y, Sasano S, Oyama K, et al. Lung cancer associated with sarcoidosis. Jpn J Thorac Cardiovasc Surg 2003;51 (1): 21-24.
223. Cheung OY, Muhm JR, Helmers RA, et al. Surgical pathology of granulomatous interstitial pneumonia. Ann Diagn Patho 2003;7(2):127-138.
224. Newman LS. Metals that cause sarcoidosis. Semin Respir Infect 1998;13(3):212-220.
225. Sharma OP, Fujimura N. Hypersensitivity pneumonitis: a noninfectious granulomatosis. Semin Respir Infect 1995; 10(2):96-106.
226. Freiman DG, Hardy HL. Beryllium disease. The relation of pulmonary pathology to clinical course and prognosis based on a study of 130 cases from the U.S. beryllium case registry. Hum Patho 11970;1(1):25-44.
227. Hardy HL. Delayed chemical pneumonitis in workers exposed to beryllium compounds. J Ind Hyg Toxicol 1946;28:197-211.
228. Dutra FR. The pneumonitis and granulomatosis peculiar to beryllium workers. Am J Pathol 1948;24:1137-1165.
229. Denardi JM, Van Ordstrand HS, Curtis GH, et al. Berylliosis; summary and survey of all clinical types observed in a twelve-year period. AMA Arch Ind Hyg Occup Med 1953;8(1):1-24.
230. Chiarappa-Zucca ML, Finkel RC, Martinelli RE, et al. Measurement of beryllium in biological samples by accelerator mass spectrometry: applications for studying chronic beryllium disease. Chern Res Toxicol 2004;17(12): 1614-1620.
231. Newman LS, Mroz MM, Balkissoon R, et al. Beryllium sensitization progresses to chronic beryllium disease: a c.F. Farver longitudinal study of disease risk. Am J Respir Crit Care Med 2005;171(1):54-60.
232. Fireman E, Haimsky E, Noiderfer M, et al. Misdiagnosis of sarcoidosis in patients with chronic beryllium disease. Sarcoidosis Vase Diffuse Lung Dis 2003;20(2): 144-148.
233. De Vuyst P, Dumortier P, Schandene L, et al. Sarcoidlike lung granulomatosis induced by aluminum dusts. Am Rev Respir Dis 1987;135(2):493-497.
234. Chen WJ, Monnat RJ Jr, Chen M, et al. Aluminum induced pulmonary granulomatosis. Hum Pathol 1978;9(6): 705-711.
235. Shaver CG. Lung changes associated with the manufacture of alumina abrasives. J Ind Hyg Tox 1947;29:145-157.
236. Shaver C. Pulmonary changes encountered in employees engaged in the manufacture of alumina abrasives. Occup Med 1948;5:718-728.
237. Redline S, Barna BP, Tomashefski JF Jr, et al. Granulomatous disease associated with pulmonary deposition of titanium. Br J Ind Med 1986;43(10):652-656.
238. Vincent M, Chemarin C, Peyrol S, et al. Use of talc and sarcoidosis. Rev Mal Respir 2004;21(4 pt 1):811-814.
239. Drent M, Bomans PH, Van Suylen RJ, et al. Association of man-made mineral fibre exposure and sarcoidlike granulomas. Respir Med 2000;94(8):815-820.
240. Sarno M. Sarcoidosis. In: Hasleton PS, ed. Spencer's pathology of the lung. 5th ed. New York: McGraw-Hill, 1996.
241. Sharma OP, Koss M, Buck F. Sarcoidosis and amyloidosis. Is the association causal or co-incidental? Sarcoidosis 1987;4(2):139-141.
242. Liebow AA. The 1. Burns Amberson lecture-pulmonary angiitis andgranulomatosis.Am Rev Respir Dis 1973;108(1): 1-18.
243. Popper HH, Klemen H, Colby TV, et al. Necrotizing sarcoid granulomatosis-is it different from nodular sarcoidosis? Pneumologie 2003;57(5):268-271.
244. Churg A, Carrington CB, Gupta R. Necrotizing sarcoid granulomatosis. Chest 1979;76(4):406-413.